bismuth-oxychloride and Neoplasms

bismuth-oxychloride has been researched along with Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for bismuth-oxychloride and Neoplasms

ArticleYear
Manganese oxide-modified bismuth oxychloride piezoelectric nanoplatform with multiple enzyme-like activities for cancer sonodynamic therapy.
    Journal of colloid and interface science, 2023, Jun-15, Volume: 640

    Sonodynamic therapy (SDT) is considered as a new-rising strategy for cancer therapeutics, but the inefficient production of reactive oxygen species (ROS) by current sonosensitizers seriously hinders its further applications. Herein, a piezoelectric nanoplatform is fabricated for enhancing SDT against cancer, in which manganese oxide (MnO

    Topics: Animals; Cell Line, Tumor; Humans; Hydrogen Peroxide; Mice; Neoplasms; Oxygen; Reactive Oxygen Species

2023
2D Ultrathin Iron Doped Bismuth Oxychloride Nanosheets with Rich Oxygen Vacancies for Enhanced Sonodynamic Therapy.
    Advanced healthcare materials, 2023, Volume: 12, Issue:30

    Sonodynamic therapy (SDT) combines ultrasound and sonosensitizers to produce toxic reactive oxygen species (ROS) for cancer cell killing. Due to the high penetration depth of ultrasound (US), SDT breaks the depth penetration barrier of conventional photodynamic therapy for the treatment of deeply seated tumors. A key point to enhance the therapeutic efficiency of SDT is the development of novel sonosensitizers with promoted ability for ROS production. Herein, ultrathin Fe-doped bismuth oxychloride nanosheets with rich oxygen vacancies and bovine serum albumin coating on surface are designed as piezoelectric sonosensitizers (BOC-Fe NSs) for enhanced SDT. The oxygen vacancies of BOC-Fe NSs provide electron trapping sites to promote the separation of e

    Topics: Biological Assay; Cell Line, Tumor; Humans; Iron; Neoplasms; Oxygen; Reactive Oxygen Species; Ultrasonic Therapy

2023